Status: Not yet recruiting
A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy
The purpose of this study is to determine the safety and efficacy of various doses of AND017 after 6 weeks of treatment in subjects with anemia of cancer who are not receiving chemotherapy.
Participants needed: 36
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Kind Pharmaceuticals LLCUpdated: Feb 27, 2026
Eligibility criteria
Non-myeloid malignancy diagnosed by cytology/histology. [+8]
Received chemotherapy, radiotherapy, and other, e.g., immunosuppressive, targete... [+12]